Episode

Is This The Cure for Protracted Withdrawal?

Podcast
Side Effects with Dr. Josef
Published
Sep 24, 2025
Duration seconds
2359
Processing state
not_requested
Canonical source
https://taperclinic.podbean.com/e/is-this-the-cure-for-protracted-withdrawal/
Audio
https://mcdn.podbean.com/mf/web/s9cu2hdc2vuttwcj/Cure_for_Protracted_Withdrawalbb4k5.mp3
JSON
/v1/public/podcasts/side-effects-with-dr-josef-6454703/episodes/is-this-the-cure-for-protracted-withdrawal
Markdown
/podcast/side-effects-with-dr-josef-6454703/is-this-the-cure-for-protracted-withdrawal.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/side-effects-with-dr-josef-6454703/episodes/is-this-the-cure-for-protracted-withdrawal/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/side-effects-with-dr-josef-6454703/is-this-the-cure-for-protracted-withdrawal.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this interview, Dr. Jeffrey Wiegers (BioReset Medical) explains what MUSE stem cells are, how they differ from traditional mesenchymal stem cells, and whether they might help after neurological injuries—concussion/TBI, stroke, chemo neuropathy, or protracted withdrawal (including PSSD). We also cover safety, side effects, why sourcing and good manufacturing practice matter, and new state-level pathways in the U.S. https://www.bioresetmedical.com/